Edition:
United States

Spark Therapeutics Inc (ONCE.OQ)

ONCE.OQ on NASDAQ Stock Exchange Global Select Market

54.50USD
16 Feb 2018
Change (% chg)

$-0.49 (-0.89%)
Prev Close
$54.99
Open
$55.00
Day's High
$55.18
Day's Low
$54.06
Volume
178,595
Avg. Vol
276,709
52-wk High
$91.75
52-wk Low
$41.06

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 1.90 -1.898
Jun '17 1.48 -2.401
Mar '17 1.27 -1.699
FY 2016 Dec '16 16.30 -1.205
Sep '16 1.30 -1.072
Jun '16 1.29 -1.044
Mar '16 1.29 -0.954
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 14 36.88 116.86 0.00 --
Quarter Ending Jun-18 14 20.57 140.84 3.90 --
Year Ending Dec-18 19 142.60 312.61 35.20 177.27
Earnings (per share)
Quarter Ending Mar-18 14 -0.83 1.47 -1.95 --
Quarter Ending Jun-18 14 -1.33 1.50 -1.99 --
Year Ending Dec-18 19 -4.12 0.93 -7.66 -1.36
LT Growth Rate (%) 1 13.00 13.00 13.00 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 178.11 34.43
P/E High - Last 5 Yrs. -- 280.23 46.75
P/E Low - Last 5 Yrs. -- 91.71 24.14
Beta -- 0.82 0.81
Price to Sales (TTM) 96.22 140.57 8.57
Price to Book (MRQ) 3.53 18.76 5.14
Price to Tangible Book (MRQ) 3.54 25.38 6.30
Price to Cash Flow (TTM) -- 118.58 25.75
% Owned Institutions -- 12.07 2.33

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.52
Dividend Yield - 5 Year Avg -- 0.20 2.01
Dividend 5 Year Growth Rate -- 1.85 5.27
Payout Ratio(TTM) -- 9.21 42.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 45.81 43.07 9.45
Sales (TTM) vs TTM 1 Yr. Ago -0.56 45.64 7.30
Sales - 5 Yr. Growth Rate -- 32.43 10.21
EPS (MRQ) vs Qtr. 1 Yr. Ago -76.98 0.41 20.15
EPS (TTM) vs TTM 1 Yr. Ago -116.92 -- --
EPS - 5 Yr. Growth Rate -- 44.88 11.48
Capital Spending - 5 Yr. Growth Rate -- 41.98 14.76

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.78 2.42
Current Ratio (MRQ) 15.79 6.17 3.38
LT Debt to Equity (MRQ) 0.17 16.64 11.85
Total Debt to Equity (MRQ) 0.23 18.80 15.12
Interest Coverage (TTM) -- -165.32 38.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 50.23 54.90
Gross Margin - 5 Yr. Avg. -- 55.34 52.64
EBITD Margin (TTM) -939.69 -- --
EBITD - 5 Yr. Avg -- -567.40 9.86
Operating Margin (TTM) -1,112.25 -697.09 1.25
Operating Margin - 5 Yr. Avg. -- -588.12 5.07
Pre-Tax Margin (TTM) -1,098.83 -664.73 2.12
Pre-Tax Margin - 5 Yr. Avg. -- -596.31 5.33
Net Profit Margin (TTM) -1,090.16 -659.23 -1.38
Net Profit Margin - 5 Yr. Avg. -- -600.20 1.62
Effective Tax Rate (TTM) -- 1.39 22.03
Effective Tax Rate - 5 Yr. Avg. -- 18.11 24.20

Efficiency

  Company industry sector
Revenue/Employee (TTM) 98,404 23,305,201 819,569,446
Net Income/Employee (TTM) -1,072,762 -626,600 95,804,981
Receivable Turnover (TTM) 5.97 15.04 5.40
Inventory Turnover (TTM) -- 2.52 3.48
Asset Turnover (TTM) 0.04 0.39 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -45.15 -1.27 10.68
Return on Assets - 5 Yr. Avg. -- -0.48 12.00
Return on Investment (TTM) -47.75 -1.15 13.54
Return on Investment - 5 Yr. Avg. -- 2.13 15.72
Return on Equity (TTM) -49.14 -20.84 14.80
Return on Equity - 5 Yr. Avg. -- -2.48 16.91
  1 Year 3 Year 5 Year
Sales % -8.52 -- --
EPS (TTM) % -104.13 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Spark Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 6.32 9.36 99 71
13 Week -26.28 -30.42 38 93
26 Week -27.14 -35.32 61 86
52 Week -15.60 -27.49 99 87
YTD 5.99 3.72 99 90
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 250
Total Shares Held: 38,331,347
3 Mo. Net Change: 2,131,901
# New Positions: 51
# Closed Positions: 50
# Increased Positions: 139
# Reduced Positions: 93
# Net Buyers: 46
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.